DELAYED-TYPE HYPERSENSITIVITY RESPONSE AFTER FIVE YEARS OF BCG VACCINATION IN CHILDREN FROM 0 TO 15 YEARS OLD IN HOCHIMINH CITY

 

Mai Nguyet Thu Hong

Pasteur Institute in HCHC

 

Delayed-Type Hypersensitivity (DTH) response after BCG vaccination was observed for evaluating the vaccine efficacy. After an observation on 800 children from 0 to 15 years old in the Pasteur Institute of HoChiMinh city, we obtained 60.25% of individuals having the DTH positive response five years after the vaccination.

These 800 children, except tuberculosis infection, were classified as follows:

 

Table 1. Classification of children

 

Number of children

0 – 5 years old

> 5 - 10 years old

> 10 – 15 years old

BCG 1

100

100

100

BCG 2

100

100

100

BCG 3

 

100

100

Plan of vaccination, revaccination and observation:

Vaccination:

The intradermic injection was applied with 0.05 mg of BCG vaccine for children under 1 year old and 0.1 mg for children older than 1 year. For the children above 3 months, the DTH test was realized preliminarily for the vaccination.

The response was considered as positive when the induration exhibited a diameter larger than 6 mm. DTH response was recorded at 1, 2, 3, 4, 5 years after vaccination.

Revaccination:

All of chidren who had the DTH negative response 6 months after BCG vaccination, were revaccinated with 0.1mg of BCG vaccine. The revaccination was realized two times only. The DTH response was also observed after 1, 2, 3, 4 and 5 years after BCG vaccination.

Results

After observating on 800 children from 0 to 15 years old (1993–1997), we obtained the following results:

After five years of the first BCG vaccination, 49 – 70% of individuals had DTH positive response.

 

Table 2. Percentage of DTH positive response after five years of the first BCG vaccination

Age

n

% DTH response positive

After
1 year

After
2 years

After
3 years

After
4 years

After
5 years

0 – 1

100

100

85

75

60

49

> 1 – 5

100

90

85

75

65

56

> 5 – 10

100

100

89

70

65

57

> 10 -15

100

100

90

85

75

70

·         49 – 70% of children had DTH response positive.

After five years of the second BCG vaccination, 60 - 63% of individuals had DTH positive response.

 

Table 3. Percentage of DTH positive response after five years of the second BCG vaccination

Age

n

% DTH response positive

After
1 year

After
2 years

After
3 years

After
4 years

After
5 years

> 1 – 5

100

95

85

76

69

60

> 5 – 10

100

98

95

90

85

67

> 10 –15

100

95

80

75

65

63

* 60 - 63% of children had DTH response positive.

After five years of the second BCG vaccination, 60% of individuals had  DTH positive response.

 

Table 4. Percentage of DTH positive response after five years of the third BCG vaccination

Age

n

% DTH positive response

After
1 year

After
2 years

After
3 years

After
4 years

After
5 years

5 – 15

100

95

83

70

65

60

* 60% of children had DTH positive response.

Thus, after five years of observation on 800 children who were vaccinated one, two and three times, we found that 60.25% of individuals had DTH positive response.

 

Table 5. Percentage of DTH positive response after five years of BCG vaccination

Age

n

% DTH positive response

After
1 year

After
2 years

After
3 years

After
4 years

After
5 years

0 - 15

800

96.62

(773/800)

86.50

(692/800)

77.00

(616/800)

68.62

(549/800)

60.25

(482/800)

* 60.25% of children had DTH positive response.

 

This result (60.25%) is:

*       lower than the results in Cowall’s study (1949-1959) 98.58%; Sim (1949) in Qu’appelle with French BCG vaccine (< 3 months) 80%; Dam (1990) in Brazil with Moreau vaccine (0-12yrs) 82-90% and Vandiviere (1973) in Canada with Canada vaccine (< 20 yrs) 80%.

*       not different from the results in Dam’s study (1990) in Cameroun (17-24yrs) 63%; in Canada with the Connaught vaccine (0-18 yrs) 60% and in England with Glaxo vaccine (1 to 12 yrs) 64%.

*       higher than the results of Dam (1990) in Burma with Japan vaccine 38%, in Srilanka 20%, in Indonesia (0-5 yrs) 40% and in Columbia (0-14 yrs) 16%.

 

The difference of the results may be due to:

*       BCG strain.

*       The ecology of different atypic Mycobacteria.

*       Ethnic immunity.

*       The sanitary, economical and social conditions of different regions.

During 5 years of observation (1993-1997) on the DTH response, we found that 60.25% of 800 individuals had the delayed type hypersensitivity positive response after five years of BCG vaccination. This result demonstrated the high efficacy of BCG vaccine produced by the Pasteur Institute, HoChiMinh City.

However, with the high annual risk of Mycobacterium tuberculosis infection (3.2%) and the high rate of tuberculosis in HIV patients (8%), a program of BCG revaccination against to tuberculosis should be suggested as soon as the immunity of vaccinated children decreases.